andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment..
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
``much of this delay in implementation can be attributed to the lack of coordination and cooperation between the city and county.''.